drugset / Trial / NCT00079833
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This research study will determine if esomeprazole, when administered twice daily at 40, 80, or 120 mg doses, can control excessive stomach acid secretion.
Timeline
- Start
- 2003-11
- Primary completion
- —
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 40 mg | — |
| Subject | Esomeprazole | Small molecule | 80 mg | — |
| Subject | Esomeprazole | Small molecule | 120 mg | — |